These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6619384)

  • 1. Inhibition of wound healing by topical steroids.
    Marks JG; Cano C; Leitzel K; Lipton A
    J Dermatol Surg Oncol; 1983 Oct; 9(10):819-21. PubMed ID: 6619384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and evaluation of ointment and cream vehicles for a new topical steroid, fluclorolone acetonide.
    Malone T; Haleblian JK; Poulsen BJ; Burdick KH
    Br J Dermatol; 1974 Feb; 90(2):187-95. PubMed ID: 4819137
    [No Abstract]   [Full Text] [Related]  

  • 3. Objective measurement of topically applied corticosteroids.
    Király K; Soós G
    Dermatologica; 1976; 152 Suppl 1():133-7. PubMed ID: 955233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioassay system for formulations of topically applied glucocorticosteroids.
    Stoughton RB
    Arch Dermatol; 1972 Dec; 106(6):825-7. PubMed ID: 4639246
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of corticosteroids on human epidermal mitotic activity.
    Fisher LB; Maibach HI
    Arch Dermatol; 1971 Jan; 103(1):39-44. PubMed ID: 4321801
    [No Abstract]   [Full Text] [Related]  

  • 6. The evaluation of a novel corticosteroid formulation, fluocinonide in "FAPG" base, in the blanching test.
    Coldman MF; Lockerbie L; Laws EA
    Br J Dermatol; 1971 Dec; 85(6):573-6. PubMed ID: 4947552
    [No Abstract]   [Full Text] [Related]  

  • 7. Tachyphylaxis to topical steroid measured by histamine-induced wheal suppression.
    Singh G; Singh PK
    Int J Dermatol; 1986 Jun; 25(5):324-6. PubMed ID: 3721670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative blanching activities of proprietary diflucortolone valerate topical preparations.
    Coleman GL; Kanfer I; Haigh JM
    Dermatologica; 1978; 156(4):224-30. PubMed ID: 342295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Remarks on the percutaneous absorption of corticoids].
    Rimbaud P; Meynadier J
    Ann Dermatol Syphiligr (Paris); 1968; 95(3):263-7. PubMed ID: 5697207
    [No Abstract]   [Full Text] [Related]  

  • 10. Measurement of dermal atrophy induced by topical steroids using a radiographic technique.
    James MP; Black MM; Sparkes CG
    Br J Dermatol; 1977 Mar; 96(3):303-5. PubMed ID: 322693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Various vagaries of vasoconstriction.
    Burdick KH
    Arch Dermatol; 1974 Aug; 110(2):238-42. PubMed ID: 4855376
    [No Abstract]   [Full Text] [Related]  

  • 12. An improved method of assessing topical corticosteroid activity.
    Barnes H; Gaylarde PM; Brock AP; Sarkany I
    Br J Dermatol; 1975 Oct; 93(4):459-64. PubMed ID: 1201192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay of topical corticosteroids. Efficacy of suppression of experimental Rhus dermatitis in humans.
    Kaidbey KH; Kligman AM
    Arch Dermatol; 1976 Jun; 112(6):808-13. PubMed ID: 133636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of clobetasone butyrate and other topical steroids on skin thickness of the domestic pig.
    Winter GD; Wilson L
    Br J Dermatol; 1976 May; 94(5):545-50. PubMed ID: 1268065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onset of the vasoconstrictor effect of diflucortolone valerate, betamethasone valerate, and fluocinolone acetonide ointments applied for varying periods under occlusive dressings.
    Szadurski J; Renz F; Gasser D
    Dermatologica; 1976; 153(4):236-42. PubMed ID: 1017533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Penetration of various labelled steroids into human skin].
    Zesch A; Schaefer H
    Arzneimittelforschung; 1973 Mar; 23(3):415-9. PubMed ID: 4740126
    [No Abstract]   [Full Text] [Related]  

  • 17. Utilization of epidermal phospholipase A2 inhibition to monitor topical steroid action.
    Norris JF; Ilderton E; Yardley HJ; Summerly R; Forster S
    Br J Dermatol; 1984 Jul; 111 Suppl 27():195-203. PubMed ID: 6743552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mometasone furoate ointment and cream 0.1 percent in treatment of psoriasis: comparison with ointment and cream formulations of fluocinolone acetonide 0.025 percent and triamcinolone acetonide 0.1 percent.
    Medansky RS; Bressinck R; Cole GW; Deeken JH; Ellis CN; Guin JD; Herndon JH; Lasser AE; Leibsohn E; Menter MA
    Cutis; 1988 Nov; 42(5):480-5. PubMed ID: 3058398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ON THE ANTI-INFLAMMATORY EFFECT OF DIFFERENT STEROID OINTMENTS ON THE HUMAN SKIN DETERMINED ON PYREXAL ERYTHEMA].
    HEITE HJ; KALKOFF KW; KOHLER H
    Arzneimittelforschung; 1964 Mar; 14():222-6. PubMed ID: 14235994
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of tropical application of steroids on the skin].
    Tagami H
    Hifuka Kiyo; 1971 Feb; 66(1):1-45. PubMed ID: 5170320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.